Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

270.00
-3.1400-1.15%
Post-market: 269.50-0.5000-0.19%19:23 EDT
Volume:7.22M
Turnover:1.95B
Market Cap:650.51B
PE:31.27
High:272.91
Open:271.97
Low:269.55
Close:273.14
52wk High:276.47
52wk Low:173.33
Shares:2.41B
Float Shares:2.40B
Volume Ratio:1.18
T/O Rate:0.30%
Dividend:5.24
Dividend Rate:1.94%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:25.74%
ROA:8.59%
PB:7.66
PE(LYR):24.47

Loading ...

US FDA - Issues Early Alert on Abiomed Heart Pump Controller Purge Cassette Issue

THOMSON REUTERS
·
5 hours ago

Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Johnson & Johnson (JNJ)

TIPRANKS
·
Yesterday

Johnson & Johnson (JNJ) Wins FDA Approval For First Warm Autoimmune Hemolytic Anemia Treatment

Simply Wall St.
·
Yesterday

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Reuters
·
Aug 25

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

Reuters
·
Aug 25

FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment

Reuters
·
Aug 25

FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients

THOMSON REUTERS
·
Aug 25

Johnson & Johnson Stock Shines on Dividends and Lung Cancer Bet

TIPRANKS
·
Aug 22

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

TIPRANKS
·
Aug 22

Novavax Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Aug 22

Johnson & Johnson Names New Vice President for Litigation

Reuters
·
Aug 22

Stocks Ex-Dividend August 25

Dow Jones
·
Aug 22

Three Scientists Beat J&J's Defamation Suit over Talc Research

Reuters
·
Aug 22

Johnson & Johnson Says Multiple Myeloma Treatment Approved by European Commission

MT Newswires Live
·
Aug 21

Perrigo Co. PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 21

Does J&J’s MONARCH QUEST 3 Approval and MedTech Momentum Change The Bull Case For Johnson & Johnson (JNJ)?

Simply Wall St.
·
Aug 21

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

BOARD OF DIRECTORS OF J & J SNACK FOODS CORP. APPOINTS ROY C. JACKSON AS LEAD INDEPENDENT DIRECTOR

GlobeNewswire
·
Aug 20